Earnings
BHVN
74.40
-1.89%
-1.43
Currencies: USD
Items
Net Income
Depreciation and Amortization
Deferred Tax
Unamortized Expenditures
Accrued Expenses
Share-based Compensation
Assets Disposal
Financial Expenses
Investment Loss
Working Capital Change
Other Items
Operating Activities
Purchases of Fixed Assets
Proceeds from Disposal of Fixed Assets
Investment Expenditure
Investment Income
Other Investing Activities
Investing Activities
Issuance of Capital Stock
Issuance of Bonds
Proceeds from Borrowings
Dividend Payments
Repayment of Borrowings
Buyback Payments
Stock Incentive Compensation
Other Financing Activities
Financing Activities
Effect of Exchange Rate Changes 
Net Increase in Cash,Cash Equivalents
FY 2020-12-31
-768.62M
9.45M
--
--
--
--
163.09M
--
--
-106.81M
--
-702.88M
-43.87M
--
--
--
-226.01M
-269.88M
321.76M
261.76M
--
--
--
--
--
--
788.82M
439.00K
-183.50M
FY 2019-12-31
-528.80M
0.00
0.00
--
--
--
110.51M
--
--
40.97M
--
-377.33M
-2.53M
--
--
--
-1.25M
-3.78M
435.74M
0.00
--
--
--
--
--
--
434.59M
--
53.48M
FY 2018-12-31
-240.92M
0.00
0.00
--
--
--
36.99M
--
--
6.79M
--
-197.14M
-4.17M
--
--
--
-6.38M
-10.54M
237.40M
0.00
--
--
--
--
--
--
340.46M
--
132.78M
FY 2017-12-31
-127.19M
0.00
9000.00
--
--
--
31.78M
--
--
583.00K
--
-94.81M
-541.00K
--
--
--
-6.50M
-7.04M
220.42M
-5.00M
--
--
--
--
--
--
209.76M
--
107.90M
FY 2016-12-31
-63.53M
5000.00
-9000.00
--
--
--
31.20M
--
--
2.83M
--
-29.50M
-26.00K
--
--
--
-3.13M
-3.15M
51.47M
5.00M
--
--
--
--
--
--
54.76M
--
22.11M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out BHVN latest annual and quarterly financial reports. There are also historical financial reports for you to reference. You can analyze Biohaven Pharma recent business situations by check its cash flow statements, balance sheets, income statements and other tables. Comprehensive data may help you to understand and analyze BHVN development prospects in various aspects, and this information may help you to better grasp the Biohaven Pharma operation.